SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001069530-19-000032
Filing Date
2019-08-12
Accepted
2019-08-12 16:07:20
Documents
45
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sava-20190630x10q.htm 10-Q 803252
2 EX-4.1 sava-20190630xex4_1.htm EX-4.1 9096
3 EX-31.1 sava-20190630xex31_1.htm EX-31.1 25571
4 EX-31.2 sava-20190630xex31_2.htm EX-31.2 25270
5 EX-32.1 sava-20190630xex32_1.htm EX-32.1 20385
6 GRAPHIC sava-20190630xex4_1g001.jpg GRAPHIC 365103
7 GRAPHIC sava-20190630xex4_1g002.jpg GRAPHIC 79261
  Complete submission text file 0001069530-19-000032.txt   3602573

Data Files

Seq Description Document Type Size
8 EX-101.INS sava-20190630.xml EX-101.INS 626767
9 EX-101.SCH sava-20190630.xsd EX-101.SCH 22683
10 EX-101.CAL sava-20190630_cal.xml EX-101.CAL 23441
11 EX-101.DEF sava-20190630_def.xml EX-101.DEF 51416
12 EX-101.LAB sava-20190630_lab.xml EX-101.LAB 157558
13 EX-101.PRE sava-20190630_pre.xml EX-101.PRE 136535
Mailing Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731
Business Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29959 | Film No.: 191016575
SIC: 2834 Pharmaceutical Preparations